ENDRA Life Sciences (NDRA) Total Non-Current Liabilities (2019 - 2021)
Historic Total Non-Current Liabilities for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2021 value amounting to $280829.0.
- ENDRA Life Sciences' Total Non-Current Liabilities fell 1380.43% to $280829.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $280829.0, marking a year-over-year decrease of 1380.43%. This contributed to the annual value of $608992.0 for FY2020, which is 7764.61% up from last year.
- ENDRA Life Sciences' Total Non-Current Liabilities amounted to $280829.0 in Q1 2021, which was down 1380.43% from $608992.0 recorded in Q4 2020.
- In the past 5 years, ENDRA Life Sciences' Total Non-Current Liabilities registered a high of $645450.0 during Q2 2020, and its lowest value of $280829.0 during Q1 2021.
- Over the past 3 years, ENDRA Life Sciences' median Total Non-Current Liabilities value was $358915.0 (recorded in 2019), while the average stood at $455767.9.
- Per our database at Business Quant, ENDRA Life Sciences' Total Non-Current Liabilities surged by 7764.61% in 2020 and then tumbled by 1380.43% in 2021.
- Quarter analysis of 3 years shows ENDRA Life Sciences' Total Non-Current Liabilities stood at $342812.0 in 2019, then skyrocketed by 77.65% to $608992.0 in 2020, then plummeted by 53.89% to $280829.0 in 2021.
- Its Total Non-Current Liabilities was $280829.0 in Q1 2021, compared to $608992.0 in Q4 2020 and $627573.0 in Q3 2020.